12:00 AM
 | 
Jun 04, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

INNO-206: Additional Phase Ib/II data

Data from 16 evaluable patients with soft tissue sarcoma (STS) in an open-label, dose-escalation Phase Ib/II trial showed that IV INNO-206 given on day 1 of each 21-day cycle for up to 8 consecutive cycles...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >